Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The drugs in question are known to scientists as GLP-1 agonists — so named because they imitate glucagon-like peptide-1, a ...

Ozempic is one of the hottest drugs on the market, and it’s time regulatory bodies employed stricter safeguarding practices when prescribing this “miracle” drug. In 2018, Ozempic, a glucagon-like ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

The University of Pittsburgh Medical Center (UPMC) indicated increased medical utilization and rising pharmacy costs as reasons for its $371 million operating loss for the first nine months of the ...

They've been dubbed 'game-changers' in the world of obesity, making the seemingly impossible, possible - significant weight ...

CHRISTMAS is famously a period of indulgences and there’s nothing wrong with partaking in a mince pie or roast with all the trimmings. Many of us wait until New Year for a health reset, but ...

A new study suggests that popular weight loss drugs may reduce the risk of suicide in adolescents. KYW medical editor Dr. Brian McDonough has more.

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...